| Ningbo Kilo Biotechnology Co., Ltd. | China | |||
|---|---|---|---|---|
![]() | www.kilobio.com | |||
![]() | +8613989352104 | |||
![]() | terry.zhang@kilobio.com | |||
![]() | QQ Chat | |||
![]() | WeChat: Wenzhou Medical University | |||
| Chemical distributor since 2023 | ||||
| chemBlink Standard supplier since 2023 | ||||
| Classification | Biochemical >> Peptide |
|---|---|
| Name | Adipotide |
| Synonyms | (2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-6-amino-2-[[(2R)-2-amino-3-sulfanylpropanoyl]amino]hexanoyl]amino]acetyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]hexanoic acid |
| Molecular Structure | ![]() |
| Molecular Formula | C111H206N36O28S2 |
| Molecular Weight | 2557.18 |
| Protein Sequence | CKGGRAKDCGGKLAKLAKKLAKLAK |
| CAS Registry Number | 859216-15-2 |
| SMILES | C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N |
| Density | 1.4±0.1 g/cm3 Calc.* |
|---|---|
| Index of refraction | 1.633 (Calc.)* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software. |
|
Adipotide was designed around a question about the blood supply to white adipose tissue. Rather than directing a peptide at appetite pathways, researchers linked a targeting element to a segment intended to trigger cell death. Their aim was to test whether the vasculature supporting white fat could be affected preferentially. That concept, and the risks it introduces, distinguish adipotide from agents developed to influence hormonal control of appetite. In a 2011 study, researchers tested the peptidomimetic in obese monkeys. They observed loss of body weight and changes in measures of insulin resistance, alongside evidence consistent with effects on adipose blood vessels. The experiment brought an idea previously explored in rodents into a primate model. Moving between species was scientifically meaningful, but it was not the same as demonstrating safety or effectiveness in humans. The study also described renal effects. This matters to the underlying design: a targeting segment changes where a molecule tends to accumulate or act, but it does not create an absolute boundary around the intended tissue. Exposure elsewhere, clearance, or products of metabolism can contribute to adverse effects. Demonstrating an intended effect and defining unwanted effects are parts of the same assessment, not separate stories to report selectively. A vascular target also changes how results should be interpreted. An effect in the vessel lining could alter the support that surrounding cells receive without requiring direct action on every fat cell. Conversely, a later tissue change alone does not prove which cell type responded first. Evidence about location and timing helps distinguish the proposed sequence of events from a more general change observed after treatment. Body weight by itself cannot explain which tissue changed or why. Measurements of body composition and tissue response help distinguish the vascular hypothesis from other possible explanations for a change in weight. The case is valuable as a preclinical experiment on tissue targeting and the limits of selectivity. It does not establish adipotide as a human weight-loss treatment or support the use of materials sold outside a controlled research setting. References: 1. Barnhart KF et al. A peptidomimetic targeting white fat in obese monkeys. Sci Transl Med (2011). https://pubmed.ncbi.nlm.nih.gov/22072637/ 2. PubChem. Adipotide identity record, CID 163360068. https://pubchem.ncbi.nlm.nih.gov/compound/163360068 |
| Market Analysis Reports |